| Trial | Title | Study Record Detail | Phase | Sponsor/Collaborator |
|---|---|---|---|---|
| A Study of DMOT4039A in Patients With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer | NCT01469793 | Phase I | Genentech, Inc. | |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | NCT01832116 | Phase I | University Medical Centre Groningen, The Netherlands / VU University Medical Center / Genentech, Inc.; Prof.dr. E.G.E. de Vries, (University Medical Centre Groningen) |
DMOT4039A is also known as RG7600 (Genentech/Roche)
Last Editorial Review: July 29, 2015
